BALCAO · PHARMACEUTICAL PREPARATIONS
PyroGenesis Canada Inc. PYRGF
4 fiscal years on record · CAD · FY2022 reported · SEC filings only
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
CAD 19.0M
Revenue, FY2022 · full 4-year series below
Revenue CAD M
Net income CAD M
FY2022 · Revenue 19.0 · Net income -32.2
15M30M-15M-30M
20192022
Compound annual growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−169 cents
lost on every revenue dollar
Operating margin
Net margin
FY2022 · Operating -122.0% · Net -169.2%
100%200%-50%-100%-150%
201920202022
ROE
FY2022 · ROE -111.6%
-50%-100%
201920202022
Three returns, three denominators.
Each CAD of equity lost 112 cents this year.
The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · CAD
row low → row highnegative—not applicable◌not available in our data
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue CAD B | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income CAD B | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA CAD B | ◌ | ◌ | ◌ | ◌ |
| Income tax CAD B | 0.0 | −0.0 | 0.0 | ◌ |
| Net income CAD B | −0.0 | −0.0 | 0.0 | −0.0 |
| Free cash flow CAD B | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted CAD | −0.19 | −0.23 | 0.27 | −0.07 |
| Dividend / sh CAD | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — |
| ROE % | −111.6 | −76.7 | — | — |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Compare
This company against its peers
PyroGenesis Canada Inc.vsMindWalk Holdings Corp.Same industry: Pharmaceutical PreparationsPyroGenesis Canada Inc.vsMedicure Inc.Same industry: Pharmaceutical PreparationsPyroGenesis Canada Inc.vsAdastra Holdings Ltd.Same industry: Pharmaceutical PreparationsPyroGenesis Canada Inc.vsAvricore Health Inc.Same industry: Pharmaceutical PreparationsPyroGenesis Canada Inc.vsOrganigram Global Inc.Same industry: Pharmaceutical Preparations
Provenance
Company facts, as filed
How we verify · 0 failures in 20 reconciliationsAUDITED
Reconciled in 4 of the 4 fiscal years we could check. 24 checks were skipped: the balance sheet is not tagged before 2019. 12 checks were skipped: EPS is not tagged before 2019. 12 checks were skipped: revenue is not tagged before 2019.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A8
Fiscal year endsDecember 31
SEC categoryemerging growth company
Data on record since2019